Many states are passing laws requiring anaphylaxis emergency preparedness plans that permit schools to stock emergency supplies of epinephrine auto-injectors. Check the progress in your state.
Allergy & Asthma Day Capitol Hill
Allergy & Asthma Network calls on Congress to address issues that impact the lives of people with asthma, allergies, anaphylaxis and related conditions.
FDA’s Proposed New Paradigm: Techno Medicine Shifts Costs and Risks to Patients
FDA posted a “new paradigm” for public consideration – one in which routine diagnostic and treatment decisions would shift from our physicians to patients and pharmacists and/or other technologies. Read more here.
Deceptive allergy testing practices
New allergy testing and immunotherapy schemes sweeping the country put patients at risk and fleece government and private insurance. How can you ensure quality care for your family?
Medications at School
Find out if your state protects students’ rights to carry and self-administer prescribed asthma and anaphylaxis medications.
Congressional Asthma and Allergy Caucus
Allergy & Asthma Network supports this bipartisan group of members of Congress dedicated to improving the lives of people with asthma and severe allergies.
NIH Guidelines for the Diagnosis and Management of Asthma
The National Asthma Education and Prevention Program (NAEPP)’s Expert Panel Report #3 (EPR-3) is a comprehensive, evidence-based set of guidelines for healthcare professionals treating asthma.
CHASM — The Consumer Health Alliance for Safe Medication
For questions and to get involved in Allergy & Asthma Network’s advocacy efforts, contact Kimberly Turner, Director of Government Affairs, firstname.lastname@example.org or 800.878.4403.